Last reviewed · How we verify

SODIUM IODIDE I 131 — Competitive Intelligence Brief

SODIUM IODIDE I 131 (SODIUM IODIDE I 131) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed sodium-iodide symporter (NIS), thyroid peroxidase Small molecule Live · refreshed every 30 min

Target snapshot

SODIUM IODIDE I 131 (SODIUM IODIDE I 131). Iodide is transported and concentrated in thyroid cells, oxidized to iodinium, and used to iodinate thyroglobulin, with I-131's beta emission causing the therapeutic effect.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SODIUM IODIDE I 131 TARGET SODIUM IODIDE I 131 marketed sodium-iodide symporter (NIS), thyroid peroxidase 1982-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SODIUM IODIDE I 131 — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-iodide-i-131. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: